Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome

By Kevin Davies, PhD
 

SURVEY QUESTIONS

1. Please classify your organization.
 
2. What is your role in your organization? 
3. What is your chief application of DNA sequencing?
 
4. What organisms do you chiefly sequence?
 
5. Do you have experience with any next-generation sequencing technology?
 
6. Which next-generation sequencing platform do you feel holds the most promise?
 
7. Which applications will benefit most from next-generation sequencing?
 
8. What area of disease research will benefit most from next-generation sequencing?
 
9. What is the biggest technical concern about next-generation sequencing platforms?
 
10. What do you think of the reported cost of next-generation sequencing platforms (assume a range of $300,000–$600,000)?
 
11. What do you predict will be the cost of full human genome sequencing by 2010?
 
12. Do you think one platform will emerge dominant, as ABI did in Sanger sequencing?
 
13. Do you foresee a role for Sanger sequencing (capillary electrophoresis) after 2010?
 
14. Does society need Congress to pass GINA (Genetic Information Nondiscrimination Act)?